DrugPatentWatch Database Preview
BRIDION Drug Profile
or, see our see our flat-rate plans
Which patents cover Bridion, and when can generic versions of Bridion launch?
This drug has fifty-four patent family members in twenty-nine countries.
The generic ingredient in BRIDION is sugammadex sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sugammadex sodium profile page.
Summary for BRIDION
| International Patents: | 54 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 2 |
| Clinical Trials: | 37 |
| Patent Applications: | 1 |
| DailyMed Link: | BRIDION at DailyMed |
Pharmacology for BRIDION
| Ingredient-type | gamma-Cyclodextrins |
Synonyms for BRIDION
| 343306-71-8 |
| 361LPM2T56 |
| CHEBI:90953 |
| DB06206 |
| Org 25969 |
| ORG-25969 |
| SCHEMBL13917069 |
| Sugammadex |
| Sugammadex [USAN:INN:BAN] |
| UNII-361LPM2T56 |
US Patents and Regulatory Information for BRIDION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Non-Orange Book US Patents for BRIDION
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,670,340 | 6-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
or, see our see our flat-rate plans
International Patents for BRIDION
Supplementary Protection Certificates for BRIDION
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C031/2008 | Ireland | ➤ Sign Up | SPC031/2008: 20090428, EXPIRES: 20230724 |
| 2008000068 | Germany | ➤ Sign Up | PRODUCT NAME: SUGAMMADEX ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
| C0052 | France | ➤ Sign Up | PRODUCT NAME: SUGAMMADEX SODIUM; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
| 47/2008 | Austria | ➤ Sign Up | PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRÄGLICHES SALZ HIERVON |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
